1 / 5

Clinical Relevance of Clot Selectivity

Clinical Relevance of Clot Selectivity. Action of Clot-Selective Agents. Action of Non-Clot-Selective Agents. (TNK-tPA, staphylokinase, t-PA). (r-PA, SK, n-PA, UK). Clot-selective Clot Blood vessel plasminogen activators. Non-clot-selective Clot Blood vessel plasminogen activators.

neil-carroll
Télécharger la présentation

Clinical Relevance of Clot Selectivity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Relevance of Clot Selectivity Action of Clot-Selective Agents Action of Non-Clot-Selective Agents (TNK-tPA, staphylokinase, t-PA) (r-PA, SK, n-PA, UK) Clot-selective Clot Blood vessel plasminogen activators Non-clot-selective Clot Blood vessel plasminogen activators

  2. TIMI-10B: Clinical Evidence of Increased Fibrin Specificity with TNK-tPA Fibrinogen Plasminogen 30 40 40 40 30 30 30 30 30 50 40 50 40 40 TNK-tPA 50 50 50 50 Percent Changes in Parameters (median) TNK-tPA A A A A A alteplase (t-PA) A alteplase (t-PA) 1 1 Hours Post-Dose Hours Post-Dose Cannon CP, Gibson CM, McCabe CH et al. Circulation. 1998;98:2805-2814.

  3. Lower Fibrinogen Levels Are Associated with Bleeding Wintrobs Clinical Hematology 9th Edition 100 mg / dl is needed for normal hemostasis Fibrinogen mg/dl Bleed Don’t Bleed Melerhenrich et al, Int J Cardiol 1998

  4. Fibrinogen Depletion and Bleeding Adapted from Smalling et al, Circ 1995;2725-2732 TNK: Fibrinogen remains within 10-15% of baseline TNK Wintrobs Clinical Hematology 9th Edition 100 mg / dl is needed for normal hemostasis

  5. ASSENT-2: Significantly Fewer Noncerebral Bleeding Events With TNK-tPA TNK-tPA t-PA P Value (n=8,461) (n=8,488) 26.4 29.0 0.0003 Total bleeds (%) 4.7 5.9 0.0002 Major bleeds (%) 21.8 23.0 0.0553 Minor bleeds (%) Units transfused 4.3 5.5 0.0002 Any - 1-2 units 2.6 3.2 - >2 units 1.7 2.2 ASSENT-2 Investigators. Lancet. 1999;354:716-722.

More Related